It is a financial services private limited company based in Mumbai, Maharashtra, India, established in 1980.
1980 | Mumbai, Maharashtra, India | AmalgamatedMexin Medicaments Private Limited, a amalgamated private limited company, was established on 14 January 1980 in Mumbai, Maharashtra, India. Engaging in diversified financial services within the financial and insurance service sector, it holds CIN: U24100MH1980PTC022105. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹4.25 Cr.
It upholds a compliant status. Its leadership includes Pranay Premchand Godha (Director), Prashant Premchand Godha (Director), Premchand Gigalal Godha (Director). Past directors included Prakash Chandra Kothari, Pranay Premchand Godha, Nirmal Kumar Gigalal Jain. It holds ₹8.37 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 203A, Vastu Prestige New Link Road, Andheri (W), Mumbai, Maharashtra, 400053.
U24100MH1980PTC022105
022105
14 January 1980
₹6.00 Cr
₹4.25 Cr
Roc Mumbai
Unlisted
Amalgamated
Explore comprehensive insights into Mexin Medicaments Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pranay Premchand Godha | Director | 07 Sep 2015 | Current |
| Prashant Premchand Godha | Director | 07 Sep 2015 | Current |
| Premchand Gigalal Godha | Director | 25 Sep 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Feb 2013 | Past |
| Pramod Abcsdd | Director | 18 Dec 2008 | Past |
| Pramod Abcsdd | Director | 31 Dec 2018 | Past |
| Pramod Abcsdd | Director | 07 Sep 2015 | Past |
| Pramod Abcsdd | Director | 31 Mar 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mexin Medicaments Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.22% decrease. The company also saw a substantial fall in profitability, with a 66.42% decrease in profit. The company's net worth Soared by an impressive increase of 286.54%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Mexin Medicaments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹83,741,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 1997 | The Vysya Bank Ltd. | ₹4.25 Cr | Open |
| 27 Nov 1994 | State Bank Of India | ₹1.18 Cr | Open |
| 09 Aug 1994 | Union Bank Of India | ₹4.90 M | Open |
| 20 Dec 1991 | State Bank Of India | ₹1.18 Cr | Open |
| 10 Dec 1991 | State Bank Of India | ₹0.89 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Mexin Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mexin Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mexin Medicaments's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Mexin Medicaments Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Mexin Medicaments Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Premchand Gigalal Godha was appointed as a Director was appointed as a Director on 25 Sep 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.
Pranay Premchand Godha was appointed as a Director was appointed as a Director on 07 Sep 2015 & has been associated with this company since 10 years 2 months . was recorded as a recent event.
Prashant Premchand Godha was appointed as a Director was appointed as a Director on 07 Sep 2015 & has been associated with this company since 10 years 2 months . was recorded as a recent event.
The activity A charge with The Vysya Bank Ltd. amounted to Rs. 4.25 Cr with Charge ID 90371690 was registered on 31 Mar 1997. was completed.
The CIN of Mexin Medicaments Private Limited is U24100MH1980PTC022105.
Mexin Medicaments Private Limited is headquartered at 203A, Vastu Prestige New Link Road, Andheri (W), Mumbai, Maharashtra, 400053.
Mexin Medicaments Private Limited was incorporated on 14 January 1980.
The current directors of Mexin Medicaments Private Limited are
The primary industry of Mexin Medicaments Private Limited is Financial And Insurance Service.
Mexin Medicaments Private Limited is unlisted.
The authorized capital of Mexin Medicaments Private Limited is ₹6.00 Cr, and the paid-up capital is ₹4.25 Cr.
The compliance status of Mexin Medicaments Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX